67 results
Page 3 of 4
S-3
EX-1.2
xgl4o9jns 2irbc1g9v
15 Aug 22
Shelf registration
5:06pm
8-K
EX-99.1
zmmy0 oaulmsiqlnhcpl
15 Aug 22
Talaris Therapeutics Announces Second Quarter Financial Results and Corporate Update
7:13am
8-K
EX-99.1
yvc5hvw
30 Jun 22
Other Events
4:54pm
8-K
aujrdu3 p3l35bd
30 Jun 22
Other Events
4:54pm
8-K
EX-99.1
8xoaiitu3fejsihlps
12 May 22
Talaris Therapeutics Announces First Quarter Financial Results and Corporate Update
4:07pm
10-K
hk8vq
17 Mar 22
Annual report
4:31pm
8-K
EX-99.1
qrk36
17 Mar 22
Talaris Therapeutics Announces Fourth Quarter and Year-End Financial Results and Provides Business Update
4:13pm
8-K
EX-99.1
2ytwl1
12 Nov 21
Talaris Therapeutics Announces Third Quarter 2021 Financial Results and Provides Business Update
7:00am
8-K
nspo0ee6cmo4nkyl
4 Nov 21
Other Events
4:02pm
8-K
EX-99.1
dmgj cglds33h
2 Nov 21
Talaris Therapeutics Announces Initiation of Phase 2 Clinical Trial of FCR001 in Delayed Tolerance Induction
4:02pm
8-K
EX-99.1
1xquyi4q dw1hg4
12 Aug 21
Talaris Therapeutics Announces Second Quarter 2021 Financial Results and Provides Business Update
10:35am
10-Q
5wjt hpe1br5yyd
14 Jun 21
Quarterly report
4:21pm
8-K
EX-99.1
b725 2r05le
14 Jun 21
Talaris Therapeutics Announces First Quarter 2021 Financial Results and Provides Business
4:07pm
424B4
7nxucnszabcfs008
10 May 21
Prospectus supplement with pricing info
4:20pm
S-1/A
x6d 5fnyn
3 May 21
IPO registration (amended)
6:07am
S-1/A
EX-1.1
d7le3erpwnaq6tfw9
3 May 21
IPO registration (amended)
6:07am